News

Arcadia Biosciences (NASDAQ:RKDA), a consumer wellness beverage company known for the Zola coconut water brand, released its second quarter results on August 14, 2025. The company reported GAAP

Plus Therapeutics (NASDAQ:PSTV), a clinical-stage biotech focused on radiotherapeutics and diagnostics for central nervous system cancers, reported its second quarter 2025 results on August 14

Annexon (NASDAQ:ANNX), a clinical-stage biopharmaceutical company developing therapies for serious autoimmune and neurodegenerative diseases, released its second quarter 2025 financial results on

bioAffinity Technologies (NASDAQ:BIAF), a biotechnology company focused on noninvasive diagnostics and cancer therapeutics, reported results for Q2 2025 on August 14, 2025. The most significant news

Reading International (NASDAQ:RDI), an operator of cinemas and real estate properties across the United States, Australia, and New Zealand, reported its second quarter fiscal 2025 results on August

P3 Health Partners (NASDAQ:PIII), a physician-led healthcare group focused on value-based care for Medicare Advantage members, reported results for Q2 FY2025 on August 14, 2025. The most notable

Celcuity (NASDAQ:CELC), a clinical-stage biotechnology company developing targeted therapies for cancer, released its second quarter 2025 earnings on August 14, 2025. The highlight was topline Phase

Co-Diagnostics (NASDAQ:CODX), a diagnostics technology company focused on infectious disease testing, announced its Q2 2025 results on August 14, 2025. GAAP EPS loss of $0.23 was better than

Daré Bioscience (NASDAQ:DARE), a women’s health-focused biopharmaceutical company developing new therapies and devices, announced its second quarter 2025 results on August 14, 2025. The headline

Shares of department store company Dillard's (NYSE: DDS) rallied on Thursday, up 5.4% as of 2 p.m. ET.

Dillard's reported second-quarter earnings that, while certainly not eye-opening from a growth

Advance Auto Parts(NYSE:AAP) reported second-quarter 2025 results on Aug. 14, 2025, with GAAP net sales of $2 billion, down 8% year-over-year, and adjusted earnings per share (EPS) of $0.69. The

Amcor(NYSE:AMCR) reported fiscal fourth quarter 2025 results on August 14, 2025, highlighting the completed Berry Global acquisition, new synergy targets, and a comprehensive portfolio review

Shares of leading enterprise software provider Nice (NASDAQ: NICE) had dropped 7% as of 11 a.m. ET on Thursday, according to data provided by S&P Global Market Intelligence. Nice reported

Applied Industrial Technologies(NYSE:AIT) reported its fiscal fourth quarter ended June 30, 2025, earnings on August 14, 2025, delivering record full-year sales, EBITDA, and EPS for the fiscal year

An inflation spike coming out of the coronavirus pandemic helped to boost the profits of energy companies. But after hitting a peak, oil and natural gas prices have come back down. That has taken

An inflation spike coming out of the coronavirus pandemic helped to boost the profits of energy companies. But after hitting a peak, oil and natural gas prices have come back down. That has taken

Applied Industrial Technologies (NYSE:AIT), a major distributor of industrial motion, fluid power, and automation components, reported its fiscal fourth quarter 2025 results on August 14, 2025. The

Air Industries Group (NYSEMKT:AIRI), a supplier of precision components and assemblies for the defense and aerospace industries, released its Q2 2025 earnings report on August 14, 2025. The company

Contango Ore (NYSEMKT:CTGO), an Alaska-focused gold exploration and production company, posted a record quarter in its earnings release on August 13, 2025. The company reported GAAP earnings per

Cocrystal Pharma (NASDAQ:COCP), a clinical-stage biotech focusing on antiviral drug development, released its second quarter 2025 earnings on August 14, 2025. The company’s report highlighted a

CoreCard (NYSE:CCRD), a provider of financial technology software and services, delivered its second quarter 2025 earnings on August 14, 2025. The main highlight was a surge in both revenue and

Galectin Therapeutics (NASDAQ:GALT), a clinical-stage biotech firm focused on liver fibrosis and cancer, reported its second quarter 2025 results on August 14, 2025. The most significant news was a

Qxo (NYSE:QXO), a rapidly transforming distributor of building products, released its second quarter earnings for fiscal 2025 on August 14, 2025. The most notable news was that it recorded Adjusted

FitLife Brands (NASDAQ:FTLF), a nutritional supplements company with products spanning sports nutrition, weight management, and general wellness, released its financial results for the second

Atai Life Sciences (NASDAQ:ATAI), a biotechnology company developing novel treatments for mental health conditions, reported its results for the second quarter of fiscal 2025 on August 14, 2025. The